MAI Capital Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.95M Sell
7,179
-446
-6% -$116K 0.01% 706
2026
Q2
$1.89M Sell
7,625
-381
-5% -$82.1K 0.01% 724
2026
Q1
$1.61M Sell
8,006
-32
-0.4% -$6.62K 0.01% 634
2025
Q4
$1.66M Buy
8,038
+93
+1% +$18.6K 0.01% 614
2025
Q3
$1.42M Sell
7,945
-106
-1% -$18.1K 0.01% 616
2025
Q2
$1.3M Buy
8,051
+599
+8% +$95.4K 0.01% 595
2025
Q1
$1.27M Hold
7,452
– – 0.01% 564
2024
Q4
$1.24M Buy
7,452
+41
+0.6% +$7.01K 0.01% 583
2024
Q3
$1.27M Sell
7,411
-562
-7% -$93K 0.01% 489
2024
Q2
$1.23M Hold
7,973
– – 0.01% 539
2024
Q1
$1.23M Sell
7,973
-297
-4% -$45.3K 0.01% 510
2023
Q4
$1.31M Sell
8,270
-1,500
-15% -$215K 0.02% 408
2023
Q3
$1.43M Sell
9,770
-620
-6% -$94.5K 0.02% 361
2023
Q2
$1.59M Buy
10,390
+524
+5% +$81.7K 0.02% 347
2023
Q1
$1.53M Sell
9,866
-82
-0.8% -$12.9K 0.02% 348
2022
Q4
$1.53M Sell
9,948
-425
-4% -$62.7K 0.03% 334
2022
Q3
$1.37M Sell
10,373
-1
-0% -$140 0.03% 325
2022
Q2
$1.41M Buy
10,374
+6,080
+142% +$838K 0.03% 321
2022
Q1
$640K Sell
4,294
-15
-0.3% -$2.22K 0.01% 493
2021
Q4
$698K Buy
+4,309
New +$697K 0.01% 480

Other funds holding FBT

MAI Capital Management's FBT Position: Q3 2026 in Review

MAI Capital Management reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 5.8% in Q3 2026, selling an estimated $116K and leaving 7,179 shares worth $1.95M. The position accounts for 0.01% of the portfolio, ranked #706.

MAI Capital Management first reported a position in FBT in Q4 2021 and has held it in 20 quarters since. 296 funds tracked by Wall St. Rank hold FBT as of Q3 2026.

  • MAI Capital Management held 7,179 shares of First Trust NYSE Arca Biotechnology Index Fund worth $1.95M as of Q3 2026.
  • MAI Capital Management sold 446 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2026, an estimated $116K.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.01% of MAI Capital Management's portfolio in Q3 2026, its #706 holding.
  • MAI Capital Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2021 and has held it in 20 quarters since.
  • 296 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2026.

Based on MAI Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.